{"id":"W2093988174","doi":"10.1007/s10637-012-9886-7","title":"The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines","year":2012,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Abbott Laboratories","keywords":"PARP inhibitor; Irinotecan; Cancer research; Veliparib; Poly ADP ribose polymerase; Olaparib; Oxaliplatin; DNA damage; PARP1; Cancer; Synthetic lethality; DNA repair; Base excision repair; Colorectal cancer; Biology; Medicine; Polymerase; Internal medicine; DNA; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001367419,0.0001917484,0.0002501599,0.00004339476,0.0001484843,0.00001528362,0.0000855712,0.00008931734,0.0002874398],"category_scores_gemma":[0.00003482297,0.0001312724,0.0001179482,0.0001779045,0.0003259856,0.0001429176,0.00001580432,0.00008003834,0.00004288767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004252487,"about_ca_system_score_gemma":0.0007849286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001185911,"about_ca_topic_score_gemma":0.0001050677,"domain_scores_codex":[0.9986218,0.00005588263,0.0003946777,0.0001808944,0.0004484414,0.0002983144],"domain_scores_gemma":[0.9987067,0.0003069384,0.000220433,0.000256176,0.0001629107,0.000346835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001681842,0.00252856,0.1080321,0.0003253111,0.0008634112,0.00001049413,0.01708681,0.0007989014,0.543262,0.02298043,0.2398566,0.06257349],"study_design_scores_gemma":[0.003132131,0.000395622,0.01179686,0.0001578012,0.0001143284,0.00001302931,0.0002571852,0.00009463682,0.6801432,0.001513534,0.3021861,0.0001955128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9709805,0.01207084,0.00002065276,0.01247632,0.0008654457,0.0004660412,0.00006534993,0.00006009159,0.002994742],"genre_scores_gemma":[0.9848878,0.001744735,0.001309849,0.00124297,0.002920158,0.0002036019,0.00005540506,0.0000331516,0.007602289],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1368812,"threshold_uncertainty_score":0.5353132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03616634036575846,"score_gpt":0.3192929074536835,"score_spread":0.2831265670879251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}